The LongView

The LongView

Share this post

The LongView
The LongView
Investing in an eternal human
Copy link
Facebook
Email
Notes
More

Investing in an eternal human

A write-up on a company which sells the biotech shovel in a race to solve the biggest diseases of our times.

Matas Baliukonis's avatar
Matas Baliukonis
Aug 14, 2024
∙ Paid
30

Share this post

The LongView
The LongView
Investing in an eternal human
Copy link
Facebook
Email
Notes
More
1
4
Share

Welcome all 96 subscribers that have joined me since my last post! Thank you for your continued support, everyone!


You probably don’t know this, but I am a big Bryan Johnson fan. I believe that humans don’t do nearly enough to try to prolong their lives.

Logically, I also strongly support the development of new drugs that could solve the worst diseases of today’s world. Now, investing directly in the research and development of new drugs is a risky, expensive and usually perilous process for investors (only ≈10% of biotech companies survive and it costs around $2Bn to go through the process of launching a drug).

The only way to guarantee making money? Helping the companies go through it without taking on the risk.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Matas Baliukonis
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More